Skip to main content
M

MEGIN

The startup develops non-invasive brain mapping devices that utilize advanced imaging techniques to diagnose and monitor neurological disorders such as epilepsy, brain tumors, and Alzheimer's. These devices enable healthcare professionals to accurately assess brain injuries and improve treatment outcomes for affected patients.

Coral Springs, United StatesFounded 2016732K+ followers
Updated 3 months ago

Funding

$330K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Diagnosing and monitoring neurological disorders such as epilepsy, brain tumors, and concussions often relies on invasive or less precise methods, leading to suboptimal treatment planning and outcomes. Current imaging techniques may lack the functional resolution needed to accurately map critical brain areas before intervention. This can result in unintended damage to eloquent cortex during surgery or radiation therapy, causing functional and cognitive deficits.

Solution

Croton Healthcare provides non-invasive functional brain imaging solutions using Magnetoencephalography (MEG) technology to improve the diagnosis, treatment planning, and monitoring of neurological conditions. MEG directly measures electrophysiological activity with millisecond-level temporal resolution and millimeter-level spatial accuracy, offering a detailed view of brain function. By integrating MEG with MRI, clinicians can precisely localize epileptic foci, map eloquent cortex near tumors, and assess the severity of concussions. This multi-modal approach enables more targeted and effective treatments, minimizing the risk of neurological deficits and improving the quality of life for patients with neurological disorders.

Target Audience

The primary target audience includes neurologists, neurosurgeons, oncologists, and radiologists involved in the diagnosis, treatment, and monitoring of patients with epilepsy, brain tumors, concussions, and other neurological disorders.

Features

  • Non-invasive functional brain mapping using Magnetoencephalography (MEG)
  • High temporal resolution (millisecond) and spatial accuracy (millimeter) for precise localization of brain activity
  • Integration with MRI for anatomical context and enhanced visualization
  • Applications in epilepsy, concussion, and oncology treatment planning
  • Identification of epileptic foci for improved surgical outcomes
  • Mapping of eloquent cortex to preserve critical brain functions during surgery or radiation therapy
  • Assessment of concussion severity through measurement of abnormal low-frequency brain activity
This profile is AI-generated and may contain inaccuracies.